eISSN: 2391-6052
ISSN: 2353-3854
Alergologia Polska - Polish Journal of Allergology
Current issue Archive Manuscripts accepted About the journal Supplements Special issues Editorial board Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures
 
3/2021
vol. 8
 
Share:
Share:
more
 
 
abstract:
Special paper

Statement of Polish Respiratory Society and Polish Society of Allergology on the treatment of pulmonary complications in patients after SARS-CoV-2 infection

Wojciech J. Piotrowski
1
,
Adam Barczyk
2
,
Andrzej Chciałowski
3
,
Joanna Chorostowska-Wynimko
4
,
Małgorzata Czajkowska-Malinowska
5
,
Aleksander Kania
6
,
Maciej Kupczyk
7
,
Krzysztof Sładek
6
,
Marek Kulus
8
,
Paweł Śliwiński
9

1.
Klinika Pneumonologii, I Katedra Chorób Wewnętrznych, Uniwersytet Medyczny, Łódź, Polska
2.
Katedra i Klinika Pneumonologii, Śląski Uniwersytet Medyczny, Katowice, Polska
3.
Klinika Chorób Infekcyjnych i Alergologii, Wojskowy Instytut Medyczny, Warszawa, Polska
4.
Zakład Genetyki i Immunologii Klinicznej, Instytut Gruźlicy i Chorób Płuc, Warszawa, Polska
5.
Kujawsko-Pomorskie Centrum Pulmonologii, Bydgoszcz, Polska
6.
Klinika Pulmonologii, II Katedra Chorób Wewnętrznych im. Prof. A. Szczeklika, Oddział Kliniczny Pulmonologii i Alergologii Szpitala Uniwersyteckiego w Krakowie, Wydział Lekarski, Uniwersytet Jagielloński Collegium Medicum, Kraków, Polska
7.
Klinika Chorób Wewnętrznych, Astmy i Alergii, Uniwersytet Medyczny, Łódź, Polska
8.
Klinika Pneumonologii i Alergologii Wieku Dziecięcego, Warszawski Uniwersytet Medyczny, Warszawa, Polska
9.
II Klinika Chorób Płuc, Instytut Gruźlicy i Chorób Płuc, Warszawa, Polska
Alergologia Polska – Polish Journal of Allergology 2021; 8, 3: 101–129
Online publish date: 2021/09/24
View full text
Get citation
ENW
EndNote
BIB
JabRef, Mendeley
RIS
Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
 
PlumX metrics:
The aim of this document is to provide physicians treating patients with a history of COVID-19 pneumonia with recommendations on proper diagnostics and management of respiratory sequelae associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. The expert panel provides 32 recommendations with respect to the treatment of lung consequences (including antibiotic therapy, corticosteroid therapy, and antithrombotic prophylaxis and treatment), pulmonary rehabilitation, lung transplantation, patient monitoring, and ambulatory settings. The management of patients with respiratory comorbidities (asthma, chronic obstructive pulmonary disease, lung cancer, and interstitial lung disease) and the medications used for treatment of these conditions, such as corticosteroids and antifibrotic drugs, is discussed. Presented recommendations are based on the most recent reports and aimed at providing patients post-COVID-19 respiratory sequelae with optimal standards of care.
keywords:

SARS-CoV-2 pandemic, COVID-19, respiratory sequelae, consensus



Quick links
© 2022 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.